Form 4: NHI CIO Exercises Options, Adjusts Holdings

Sentiment:

Insider Transaction Report


National Health Investors' Chief Investment Officer, Kevin Carlton Pascoe, exercised stock options and adjusted his common stock holdings.

Summary

  • Kevin Carlton Pascoe, Chief Investment Officer of National Health Investors Inc (NHI), reported transactions on January 30, 2026.
  • Pascoe exercised 8,500 stock options granted in 2023 at an exercise price of $54.73 per share.
  • Pascoe also exercised 8,500 stock options granted in 2024 at an exercise price of $57.76 per share.
  • Following these exercises, 17,000 shares of common stock were acquired.
  • Concurrently, Pascoe disposed of 13,602 shares of common stock at a price of $82.12 per share, likely to cover tax obligations related to the option exercises.
  • After all reported transactions, Pascoe's direct beneficial ownership of NHI common stock stands at 64,728 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine insider transaction related to executive compensation rather than a significant change in company fundamentals or strategic direction.

Positives

  • The exercise of stock options indicates that the Chief Investment Officer is realizing value from previously granted equity compensation.
  • The exercise prices ($54.73 and $57.76) are significantly lower than the disposal price ($82.12), suggesting a profitable transaction for the insider.

Negatives

  • The disposal of 13,602 shares reduces the insider's direct beneficial ownership, although this is a common practice for tax withholding following option exercises.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, such as the exercise of stock options and subsequent share sales for tax purposes, are common occurrences and provide routine insights into executive equity holdings rather than fundamental company performance.

Key Dates

DateDescription
02/23/2025Date exercisable for 2024 stock options
02/24/2025Date exercisable for 2023 stock options
01/30/2026Date of reported transactions (option exercises and share disposal)
02/02/2026Signature date of the reporting person
02/24/2028Expiration date for 2023 stock options
02/23/2029Expiration date for 2024 stock options

Recommendation

hold

This Form 4 details a routine exercise of stock options and subsequent sale of shares, likely for tax purposes, by a company officer. It does not provide new fundamental information about the company's performance or strategic direction that would alter an investment thesis. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to change an existing position.

Keywords

NHI, National Health Investors, insider trading, stock options, Form 4, executive compensation, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.